Book outlines importance of Alzheimer's diagnosis and therapeutic interventions

Karger Medical Publishers Book On Cutting-Edge Alzheimer's Diagnosis and Therapy, with guidance from the Alzheimer's Association. This volume advances emerging concepts for therapeutic interventions and earlier detection and diagnosis of the global epidemic and features internationally leading experts' findings on biomarkers

Addressing the urgent need for effective early diagnosis and therapy, Karger Publishers of Basel, Switzerland, publishes breakthrough advances in their new book release "Alzheimer's Disease - Modernizing Concept, Biological Diagnosis and Therapy".

Edited by Dr Maria Carrillo, PhD, Senior Director of Medical and Scientific Relations at the Alzheimer's Association, and Professor Harald Hampel, MD, MSc, chair of Psychiatry, at Goethe University in Frankfurt, Germany, the book aims to outline the current state-of-the-art knowledge as well as future perspectives on Alzheimer's disease as a decade-long continuum with the goal of advancing early detection, diagnosis and effective disease-modifying therapeutic interventions in individuals throughout all stages of Alzheimer's disease.

"This book outlines the importance of detecting Alzheimer's disease long before symptoms appear and applying disease-modifying interventions in people guided by biological markers at the earliest possible time point before symptoms of mild cognitive impairment or even dementia occur", said Harald Hampel. "Our hope is that discovering the biological changes before Alzheimer's clinical symptoms and having the ability to apply current or developing therapies will in turn slow or halt the progression of the disease", comments Maria Carillo.

Although Alzheimer's disease has escalated into an epidemic impacting millions of people and their families, straining governments and public health systems worldwide, the complex causes remain as of yet unresolved.

"Alzheimer's Disease - Modernizing Concept, Biological Diagnosis and Therapy" underscores intense worldwide efforts to enable earlier, more precise diagnosis and interventions to counter and prevent this devastating neurodegenerative disease.

In this volume, leading experts discuss emerging and novel conceptual models of Alzheimer's disease and advances in the development of surrogate markers that will improve the accuracy of diagnostic technologies. The book explains the importance of recognizing the worldwide Alzheimer's disease situation and ever-growing epidemiology, and outlines how current biological markers are auspiciously modernizing diagnosis. It highlights both current research on biomarkers and efforts to validate technologies for early and accurate detection, therapy and prevention.